Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Long Only ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated

Ann Gallo

Ann Gallo

Showing manager performance globally. You can view performance in individual jurisdictions.

About Ann Gallo

As a global industry analyst in Global Industry Research, Ann Gallo specializes in the health care services industry and conducts fundamental analysis on the companies within her industry. Ann is a member of Wellington Management’s health care team, which manages health and biotechnology sector mutual funds and hedge funds. Prior to joining Wellington Management in 1998, Ann was a health care analyst with BT Alex. Brown. She worked as an investment banker and, subsequently, a health care analyst at Piper Jaffray in Minneapolis. Previously, she was a financial analyst with Citibank N.A. and an accountant with Coopers & Lybrand. Ann received her MS in finance and applied economics from the Massachusetts Institute of Technology and her BS in accounting from Boston College.

Are you Ann Gallo?

Citywire Rating: AA rated

2014

  • JRated Plus in Jul 2014
  • ARated Plus in Aug 2014
  • SRated Plus in Sep 2014
  • ORated Plus in Oct 2014
  • NRated Plus in Nov 2014
  • DRated A in Dec 2014

2015

  • JRated AA in Jan 2015
  • FRated A in Feb 2015
  • MRated A in Mar 2015
  • ARated A in Apr 2015
  • MRated A in May 2015
  • JRated A in Jun 2015
  • JRated AA in Jul 2015
  • ARated AA in Aug 2015
  • SRated AAA in Sep 2015
  • ORated AA in Oct 2015
  • NRated AA in Nov 2015
  • DRated AAA in Dec 2015

2016

  • JRated AAA in Jan 2016
  • FRated AA in Feb 2016
  • MRated A in Mar 2016
  • ARated AA in Apr 2016
  • MRated AA in May 2016
  • JRated AA in Jun 2016
  • JRated AA in Jul 2016
  • ARated AA in Aug 2016
  • SRated AA in Sep 2016
  • ORated AA in Oct 2016
  • NRated AA in Nov 2016
  • DRated AA in Dec 2016

2017

  • JRated AA in Jan 2017
  • FRated AA in Feb 2017
  • MRated AA in Mar 2017
  • ARated AA in Apr 2017
  • MRated AA in May 2017
  • JRated AA in Jun 2017
  • JRated AA in Jul 2017
  • ARated AA in Aug 2017

Performance

Equity - Pharmaceuticals & Health Care
over : 31/07/2016 - 31/07/2017

Total Return

Month by Month Performance

Quarterly Performance

to 30/06/2017 Annual Q1 Q2 Q3 Q4
2017 11.8% 7.3%
2016 -9.1% -11.9% 6.1% 2.8% -5.3%
2015 12.7% 9.1% 4.8% -11.1% 10.9%
2014 26.5% 7.6% 4.5% 1.4% 11.0%
2013 48.4% 16.2% 3.9% 10.5% 11.3%
2012 -1.6%

Related News

Sector showdown: fighting fit in pharma

Leading the pack in pharma, Citywire Selector delves into the data.

Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.